-+ 0.00%
-+ 0.00%
-+ 0.00%

Insider Buys Additional CN¥967k In Abbisko Medicine Stock

Simply Wall St·11/16/2026 00:13:46
Listen to the news

Investors who take an interest in Abbisko Medicine Co., Ltd. (HKG:2256) should definitely note that the Founder, Yao-Chang Xu, recently paid HK$6.67 per share to buy HK$967k worth of the stock. Although the purchase is not a big one, by either a percentage standpoint or absolute value, it can be seen as a good sign.

The Last 12 Months Of Insider Transactions At Abbisko Medicine

In the last twelve months, the biggest single sale by an insider was when the Co-Founder, Hongping Yu, sold HK$1.1m worth of shares at a price of HK$12.71 per share. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. The good news is that this large sale was at well above current price of HK$6.79. So it may not tell us anything about how insiders feel about the current share price.

All up, insiders sold more shares in Abbisko Medicine than they bought, over the last year. They sold for an average price of about CN¥12.75. We are not joyful about insider selling. But the selling was at much higher prices than the current share price (HK$6.79), so it probably doesn't tell us a lot about the value on offer today. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

Check out our latest analysis for Abbisko Medicine

insider-trading-volume
SEHK:2256 Insider Trading Volume November 16th 2026

If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar).

Does Abbisko Medicine Boast High Insider Ownership?

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. A high insider ownership often makes company leadership more mindful of shareholder interests. Abbisko Medicine insiders own about HK$777m worth of shares. That equates to 17% of the company. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

So What Do The Abbisko Medicine Insider Transactions Indicate?

The recent insider purchase is heartening. On the other hand the transaction history, over the last year, isn't so positive. The recent buying by an insider , along with high insider ownership, suggest that Abbisko Medicine insiders are fairly aligned, and optimistic. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. Every company has risks, and we've spotted 1 warning sign for Abbisko Medicine you should know about.

Of course Abbisko Medicine may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.